Synergistic photothermal-chemotherapy based on the use of biomimetic magnetic nanoparticles

18Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

Abstract

MamC-mediated biomimetic magnetic nanoparticles (BMNPs) have emerged as one of the most promising nanomaterials due to their magnetic features (superparamagnetic character and large magnetic moment per particle), their novel surface properties determined by MamC, their biocompatibility and their ability as magnetic hyperthermia agents. However, the current clinical application of magnetic hyperthermia is limited due to the fact that, in order to be able to reach an effective temperature at the target site, relatively high nanoparticle concentration, as well as high magnetic field strength and/or AC frequency are needed. In the present study, the potential of BMNPs to increase the temperature upon irradiation of a laser beam in the near infrared, at a wavelength at which tissues become partially transparent, is explored. Moreover, our results also demonstrate the synergy between photothermia and chemotherapy in terms of drug release and cytotoxicity, by using BMNPs functionalized with doxorubicin, and the effectiveness of this combination therapy against tumor cells in in vitro experiments. Therefore, the findings of the present study open the possibility of a novel, alternative approach to fight localized tumors.

Cite

CITATION STYLE

APA

Jabalera, Y., Sola-Leyva, A., Carrasco-Jiménez, M. P., Iglesias, G. R., & Jimenez-Lopez, C. (2021). Synergistic photothermal-chemotherapy based on the use of biomimetic magnetic nanoparticles. Pharmaceutics, 13(5). https://doi.org/10.3390/pharmaceutics13050625

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free